SCHEMBL4962977

SCHEMBL4962977

C[N+](C)(C)C[C@@H](CC(=O)[O-])OC(=O)CO

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.75
KMT2A Q03164 4/20 0.75
CYP2C19 P33261 2/20 0.75
RECQL P46063 1/20 0.75
CYP1A2 P05177 3/20 0.69
HRH1 P35367 1/20 0.69
SLC25A20 O43772 3/20 0.63
TP53 P04637 3/20 0.63
TSHR P16473 3/20 0.63
CYP2D6 P10635 2/20 0.63
SLC6A5 Q9Y345 2/20 0.63
MAPT P10636 2/20 0.63
CYP2C9 P11712 2/20 0.63
HIF1A Q16665 2/20 0.63
KDM4E B2RXH2 1/20 0.63
CYP3A4 P08684 1/20 0.63
NFKB1 P19838 1/20 0.63
THPO P40225 1/20 0.63
HSD17B10 Q99714 1/20 0.63
CPT2 P23786 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4962982 1.00 MEN1 (0.75) MEN1KMT2ACYP2C19RECQLCYP1A2
SCHEMBL7048157 0.87 MEN1 (0.77) MEN1KMT2ACYP2C19RECQLCYP1A2
SCHEMBL3006635 0.87 MEN1 (0.77) MEN1KMT2ACYP2C19RECQLCYP1A2
SCHEMBL31011113 0.86 MEN1 (0.71) MEN1KMT2ACYP2C19RECQLCYP1A2
SCHEMBL30513874 0.86 MEN1 (0.71) MEN1KMT2ACYP2C19RECQLCYP1A2
SCHEMBL31383391 0.86 MEN1 (0.71) MEN1KMT2ACYP2C19RECQLCYP1A2
SCHEMBL288522 0.86 MEN1 (0.71) MEN1KMT2ACYP2C19RECQLCYP1A2
SCHEMBL288495 0.86 MEN1 (0.71) MEN1KMT2ACYP2C19RECQLCYP1A2
Propionyl-Carnitine SCHEMBL994714 0.86 MEN1 (1.00) MEN1KMT2ACYP2C19RECQLCYP1A2
Propionyl-Carnitine SCHEMBL156850 0.86 MEN1 (1.00) MEN1KMT2ACYP2C19RECQLCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0697397-B1 L-carnitine salt and compositions containing same AVANTGARDE SPA (IT) 1998-04-22 EP claimed
US-5591450-A L-CARNITINE GLYCOLATE ADVANTGARDE S.P.A. (IT) 1997-01-07 US claimed
EP-0697397-A1 L-carnitine salt and compositions containing same AVANTGARDE S.p.A. (IT) 1996-02-21 EP claimed
EP-0688761-A2 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses AVANTGARDE S.p.A. (IT) 1995-12-27 EP claimed
CN-115887279-B Supermolecule recombinant superpolymer collagen and preparation method and application thereof 予态(上海)生物科技有限公司 2024-09-03 CN disclosed
EP-1610760-A4 TOPICAL L-CARNITINE COMPOSITIONS LONZA AG (US) 2008-01-09 EP disclosed
EP-1610760-A2 TOPICAL L-CARNITINE COMPOSITIONS LONZA INC. (US) 2006-01-04 EP disclosed
US-20050100519-A1 Topical L-carnitine compositions LONZA INC. (US) 2005-05-12 US disclosed
WO-2004087072-A2 TOPICAL L-CARNITINE COMPOSITIONS LONZA INC. (US) 2004-10-14 WO disclosed
EP-0697397-B1 L-carnitine salt and compositions containing same AVANTGARDE SPA (IT) 1998-04-22 EP disclosed
US-5591450-A L-CARNITINE GLYCOLATE ADVANTGARDE S.P.A. (IT) 1997-01-07 US disclosed
US-5591450-A L-CARNITINE GLYCOLATE ADVANTGARDE S.P.A. (IT) 1997-01-07 US disclosed
EP-0697397-A1 L-carnitine salt and compositions containing same AVANTGARDE S.p.A. (IT) 1996-02-21 EP disclosed
EP-0697397-A1 L-carnitine salt and compositions containing same AVANTGARDE S.p.A. (IT) 1996-02-21 EP disclosed
EP-0688761-A2 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses AVANTGARDE S.p.A. (IT) 1995-12-27 EP disclosed
EP-0688761-A2 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses AVANTGARDE S.p.A. (IT) 1995-12-27 EP disclosed